Picture of AstraZeneca logo

AZN — AstraZeneca News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

AstraZeneca-Ionis drug fails to meet main goal in late-stage heart disease trial

AstraZeneca-Ionis drug fails to meet main goal in late-stage heart disease trial

- AstraZeneca AZN.L said on Thursday that its drug Wainua, made in partnership with Ionis IONS.O, failed to meet the main goal of reducing cardiovascular deaths and recurring heart problems in a late-stage trial.


(Reporting by Raechel Thankam Job in Bengaluru; Editing by Janane Venkatraman)

((RaechelThankam.Job@thomsonreuters.com;))

Recent news on AstraZeneca

See all news